Your SlideShare is downloading. ×
CURRICULUM VITAE
Angus A Wilfong, MD, FRCPC
PERSONAL:
NAME: Angus Arthur Wilfong, MD, FRCPC
POSITION: Associate Professor, Pediatrics and Neurology
Baylor College of ...
EDUCATION:
1978 High School Diploma
Central Collegiate Institute
Moose Jaw, Saskatchewan
CANADA
1983 Bachelor of Science i...
10/91-06/92 Clinical Instructor
Department of Neurology
Baylor College of Medicine
Houston, Texas
07/92-07/95 Assistant Pr...
03/00-01/01 Chief, Division of Pediatric Neurology
Department of Neurology
Medical College of Wisconsin
Milwaukee, Wiscons...
LICENSURE:
Wisconsin – 36305
Texas – J0413
Saskatchewan – 7807
CLINICAL INTERESTS:
Medical and surgical epileptology
Neona...
PUBLIC AND COMMUNITY CONTRIBUTIONS:
Regional Board Delegate for the Canadian Board of Registration of
Electroencephalograp...
RESEARCH GRANTS:
Co-Principal Investigator: Efficacy and safety of oral adjunctive vigabatrin
(Sabril) therapy compared to...
Adjunctive Therapy in Pediatric Patients with Inadequately Controlled
Partial Seizures. 2002-present.
Principal Investigat...
Vagal Nerve Stimulation for Pediatric Epilepsy. 31st
Annual Meeting of the
Upper Midwest Child Neurology Society Meeting, ...
Clinical Neurophysiology in Epilepsy. 5th
Annual Latin-American Congress
of Clinical Neurophysiology. Puebla, Mexico, 2008...
Wilfong AA and Willmore JL. Zonisamide – A Review of Experience and
Use in Partial Seizures (Invited Review). Neuropsychia...
Wilfong AA. Pediatric Epilepsy. In: Bromfield EB, Cavazos JE, Sirven JI,
eds. An Introduction to Epilepsy. Bethesda, MD: R...
Wilfong AA. Control of Intractable Photic Epilepsy with Eye Patching. 29th
Canadian Congress of Neurological Sciences Meet...
Lotze TE and Wilfong AA. Zonisamide as Potential Therapy for
Symptomatic Infantile Spasms. 31st
Annual Meeting of the Chil...
Wilfong AA, Constantine S, McCague K, D’Souza J. Oxcarbazepine Added
to Other Sodium Channel Blockers or Antiepileptic Dru...
Goldman AM, Burgess DL, Gibbs RA, Chapman KE, Wilfong AA,
Hrachovy RA, Foreman PJ, Goldsmith IL, Verma A, Hill MJ, Noebels...
Upcoming SlideShare
Loading in...5
×

CURRICULUM VITAE

972

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
972
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "CURRICULUM VITAE"

  1. 1. CURRICULUM VITAE Angus A Wilfong, MD, FRCPC
  2. 2. PERSONAL: NAME: Angus Arthur Wilfong, MD, FRCPC POSITION: Associate Professor, Pediatrics and Neurology Baylor College of Medicine Medical Director, Comprehensive Epilepsy Program Texas Children’s Hospital Houston, Texas PROFESSIONAL ADDRESS: Pediatric Neurology 6621 Fannin Street CC 1250 Houston, Texas 77030 Tel: (832) 822-1750 Fax: (832) 825-1717 Email: awilfong@bcm.edu 2
  3. 3. EDUCATION: 1978 High School Diploma Central Collegiate Institute Moose Jaw, Saskatchewan CANADA 1983 Bachelor of Science in Medicine Degree (Physiology) University of Saskatchewan Saskatoon, Saskatchewan CANADA 1986 Doctor of Medicine Degree University of Saskatchewan Saskatoon, Saskatchewan CANADA PROFESSIONAL EXPERIENCE: 07/86-06/88 Intern and Resident Department of Pediatrics Royal University Hospital University of Saskatchewan Saskatoon, Saskatchewan 07/88-06/91 Resident in Pediatric Neurology Departments of Pediatrics and Neurology Baylor College of Medicine Houston, Texas 07/91-06/91 Clinical Fellow in Electromyography Department of Neurology Baylor College of Medicine Houston, Texas 07/91-06/92 Fellow in Clinical Neurophysiology and Epilepsy Department of Neurology Baylor College of Medicine Houston, Texas 3
  4. 4. 10/91-06/92 Clinical Instructor Department of Neurology Baylor College of Medicine Houston, Texas 07/92-07/95 Assistant Professor Department of Pediatrics Royal University Hospital University of Saskatchewan Saskatoon, Saskatchewan 10/92-07/95 Medical Co-Director Clinical Neurophysiology Laboratory Royal University Hospital University of Saskatchewan Saskatoon, Saskatchewan 07/93-12/93 Acting Head Division of Pediatric Neurology Department of Pediatrics Royal University Hospital University of Saskatchewan Saskatoon, Saskatchewan 08/95-06/97 Medical Director Mercy Comprehensive Epilepsy Center Mercy Health System Janesville, Wisconsin 07/97-01/01 Assistant Professor Neurology and Pediatrics Medical College of Wisconsin Milwaukee, Wisconsin 07/97-01/01 Medical Director Comprehensive Epilepsy Program Children’s Hospital of Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin 07/07-01/01 Medical Director Clinical Neurophysiology Laboratory Children’s Hospital of Wisconsin Milwaukee, Wisconsin 4
  5. 5. 03/00-01/01 Chief, Division of Pediatric Neurology Department of Neurology Medical College of Wisconsin Milwaukee, Wisconsin 02/01-09/06 Assistant Professor Pediatrics and Neurology Baylor College of Medicine Houston, Texas 10/06- Associate Professor Pediatrics and Neurology Baylor College of Medicine Houston, Texas 02/01- Medical Director Comprehensive Epilepsy Program Texas Children’s Hospital Houston, Texas CERTIFICATION: Federation Licensing Examination (FLEX) - 1986 Licentiate of The Medical Council of Canada (LMCC) - 1992 The Royal College of Physicians and Surgeons of Canada (FRCPC) - Child Neurology, 1991 The Canadian Society of Clinical Neurophysiologists Qualifying Examination in Electroencephalography, 1992 The American Board of Psychiatry and Neurology - Child Neurology, 1993 The American Board of Psychiatry and Neurology - Clinical Neurophysiology, 1996 - Re-certification 2006 The American Board of Clinical Neurophysiology - 1997 5
  6. 6. LICENSURE: Wisconsin – 36305 Texas – J0413 Saskatchewan – 7807 CLINICAL INTERESTS: Medical and surgical epileptology Neonatal and childhood electroencephalography AWARDS: Dean of Medicine’s Grant for Research, University of Saskatchewan, 1981, 1982, 1983 Bachelor of Science in Medicine Degree Scholarship, University of Saskatchewan, 1982 Canadian Heart Foundation Summer Studentship Grant, University of Saskatchewan, 1983 Resident Research Paper Award, Texas Neurological Society, 1991 Merritt-Putnam Clinical Research Fellowship, Epilepsy Foundation of America. $25,000: 07/91-06/92 PROFESSIONAL SOCIETIES: Child Neurology Society Canadian Association for Child Neurology American Epilepsy Society American Clinical Neurophysiology Society Canadian Society of Clinical Neurophysiologists American Academy of Neurology Canadian Neurological Society Texas Medical Association 6
  7. 7. PUBLIC AND COMMUNITY CONTRIBUTIONS: Regional Board Delegate for the Canadian Board of Registration of Electroencephalograph Technologists (CBRET): 06/94-06/98 Member of the National Aquatic Emergency Care Medical Advisory Council for the Royal Life Saving Society Canada: 06/93-07/95 President, Epilepsy Saskatoon (Affiliate of Epilepsy Canada): 04/94-07/95 Corporate Board Member, Epilepsy Association of Southern Wisconsin (Affiliate of the Epilepsy Foundation of America): 11/95-06/97 Professional Advisory Board Member, Epilepsy Foundation of Southeast Texas (Affiliate of the Epilepsy Foundation of America): 02/02-present Director, Sturge-Weber Foundation Center of Excellence at Texas Children's Hospital: 07/08-present Medical Advisory Board, The Hemispherectomy Foundation: 02/09-present NATIONAL/INTERNATIONAL COMMITTEES: National Consensus Committee for the Medical Management of Epilepsy in Children and Adolescents, 1998. Student and Resident Education Committee. American Epilepsy Society, 2002-present. Membership Committee. American Epilepsy Society, 2003-present. Pediatric Epilepsy Surgery Committee. International League Against Epilepsy, 2007-present. EDITORIAL REVIEW BOARDS: Neurology Epilepsia Pediatric Neurology Journal of Pediatric Neurology Developmental Medicine & Child Neurology Neuropsychiatric Disease and Treatment British Medical Journal Point of Care Honorary Editorial Board of the International Journal of General Medicine 7
  8. 8. RESEARCH GRANTS: Co-Principal Investigator: Efficacy and safety of oral adjunctive vigabatrin (Sabril) therapy compared to placebo in children with uncontrolled complex partial seizures: A parallel group study. 1992-1994. Principal Investigator: Open follow-up study on vigabatrin (Sabril) as adjunctive therapy in children with complex partial seizures. 1994-1995. Principal Investigator: A study of Clobazam as monotherapy for the treatment of epilepsy in children. 1993-1995. Co-Investigator: PET-205: A multicenter, double-blind, placebo-controlled study to evaluate the efficacy and safety of CY-1503 (Cylexin) in the prevention of reperfusion injury in neonates and infants undergoing hypothermic cardiopulmonary bypass during surgical repair of congenital heart defects. 1998-1999. Principal Investigator: Cognitive, adaptive, and behavioral changes following vagus nerve stimulation in children and adolescents with refractory partial epilepsy. 1998-2001. Principal Investigator: An open-label clinical investigation to evaluate the safety, tolerability, and pharmacokinetics of Ganaxolone in pediatric patients with epilepsy. 1998-2001. Principal Investigator: Gabapentin Pediatric Add-On Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study in Patients With Partial Seizures. 1999-2000. Principal Investigator: Open-Label, Safety Study of Gabapentin as Adjunct Therapy in Children Aged One Month Through Four Years With Seizures Uncontrolled by Current Anticonvulsant Drugs. 1999-2000. Principal Investigator: Cognitive and Behavioral Functioning in Children with Absence Epilepsy. 1999-present. Principal Investigator: A Multicenter, Rater-Blinded, Randomized, Age- Stratified, Parallel-Group Study Comparing Two Doses of Oxcarbazepine as Monotherapy in Pediatric Patients with Inadequately Controlled Partial Seizures. 2002-present. Principal Investigator: A Multicenter, Rater-Blinded, Randomized, Age- Stratified, Parallel-Group Study Comparing Two Doses of Oxcarbazepine as 8
  9. 9. Adjunctive Therapy in Pediatric Patients with Inadequately Controlled Partial Seizures. 2002-present. Principal Investigator: Evaluation of the Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients with Partial-Onset Seizures: A 28-Week Double-Blind, Placebo-Controlled, Multicenter Study. 2002-present. Principal Investigator: A Multicenter Open-Label Assessment of the Safety of Zonisamide as Adjunctive Therapy in Patients with Primary Generalized Epilepsy. 2002-present. Co-Investigator: Measurement of Brain Metabolites Using 2-D Double- Quantum Magnetic Resonance Spectroscopy. 2002-present. Principal Investigator: NIH RO1 NS045911-01A1 Childhood Absence Epilepsy Treatment, PK-PD-Pharmacogenetics, NINDS. 9/30/03-5/31/08. EDUCATIONAL GRANTS: Chairman: Case by case lecture series for the practical management of seizure disorders in children. 1998, $205,000. INVITED LECTURES: Epilepsy Surgery. POGO-93 (Conference of Pediatrics, Obstetrics and Gynecology), Saskatoon, Saskatchewan, 1993. Advances in Epilepsy Surgery. University to the People Lecture Series, Saskatoon, Saskatchewan, 1994. Advances in Epilepsy Surgery. Neurology Update-94 (A symposium on neurology for primary care physicians), Saskatoon, Saskatchewan, 1994. New Drugs in Epilepsy. University to the People Lecture Series, Saskatoon, Saskatchewan, 1995. Who Gets Seizures and Why? Hines Lecturer: 73rd Annual Meeting of the Canadian Pediatric Society, Saskatoon, Saskatchewan, 1996. Pediatric Epilepsy: New Treatment Approaches. Epilepsy to the Year 2000 Conference, Door County, Wisconsin, 1997. 9
  10. 10. Vagal Nerve Stimulation for Pediatric Epilepsy. 31st Annual Meeting of the Upper Midwest Child Neurology Society Meeting, Madison, Wisconsin, 1998. Use of New Antiepileptic Drugs in Pediatric Patients and Management of Febrile Seizures. Midwest Advances in Epilepsy Conference, Lake Geneva, Wisconsin, 1998. Advantages and Disadvantages of Using Newer Antiepileptic Drugs in Children. Midwest Advances in Epilepsy Conference, Lake Geneva, Wisconsin, 1999. New Treatment Strategies for Epilepsy. 27th Annual Meeting of the Texas Association on Mental Retardation, Corpus Christi, Texas, 2002. Seizures and Seizure Management: Confirming Diagnosis and Assessing Treatment. 3rd Annual World Congress and Exposition on Disabilities, Orlando, Florida, 2002. Seizures: Are the New Anticonvulsants Better? 6th Annual Texas Pediatric Emergency Medicine Conference, Houston, Texas, 2002. Neurostimulation for Epilepsy. 6th Annual Texas Neurological Society Winter Conference, Austin, Texas, 2003. Nonpharmacologic Treatments for Epilepsy in People with MR/DD. 20th Annual Voice of the Retarded Conference, Washington, D.C., 2003. Surgical Approaches to Epilepsy Breakfast Seminar. 33rd Annual Meeting of the Child Neurology Society, Ottawa, Ontario, 2004. Catastrophic Epilepsies of Childhood. 12th Annual Meeting of the Central American Neurology Congress, San Salvador, El Salvador, 2005. Management of Pediatric Seizures in the Emergency Department. 9th Annual Texas Pediatric Emergency Medicine Conference. Houston, Texas, 2005. Epilepsy Treatments. 24th Annual Houston Conference on Biomedical Engineering Research. Houston, Texas, 2007. A Comprehensive Review of Epilepsy Management. Case-Based CME Symposia. American Epilepsy Society Regional Symposium. Houston, Texas, 2007. Clinical Presentation of Childhood Epilepsy. 46th Annual Meeting of the American Society of Neuroradiology. New Orleans, Louisiana, 2008. 10
  11. 11. Clinical Neurophysiology in Epilepsy. 5th Annual Latin-American Congress of Clinical Neurophysiology. Puebla, Mexico, 2008. Vagus Nerve Stimulation for Treatment in Children. 5th Annual Latin- American Congress of Clinical Neurophysiology. Puebla, Mexico, 2008. PUBLICATIONS: Thornhill JA and Wilfong AA. Lateral Cerebral Ventricle and Preoptic- Anterior Hypothalamic Area Infusion and Perfusion of β-Endorphin and ACTH to Unrestrained Rats: Core and Surface Temperature Responses. Canadian Journal of Physiology and Pharmacology. 1982;60:1267-74. Thornhill JA, Ewen M, Wilfong AA, Gregor L, and Saunders WS. Pressor Effects of Systemic Administration of Methionine and Leucine Enkephalins in the Conscious Rat. Canadian Journal of Physiology and Pharmacology. 1986;64:1353-60. Wilfong AA, Parke JT, and McCrary JA III. Opsoclonus-Myoclonus with Beckwith-Wiedemann Syndrome and Hepatoblastoma. Pediatric Neurology. 1992;8(1):77-9. Wilfong AA and Fernandez F. Myasthenia Gravis in a Child with Sequelae of Opsoclonus-Myoclonus Syndrome. Canadian Journal of Neurological Sciences. 1992;19(1):88-9. Killian JM, Wilfong AA, Burnett L, Appel SH, and Boland D. Decremental Motor Responses to Repetitive Nerve Stimulation in ALS. Muscle and Nerve. 1994;17:747-54. Wilfong AA. Treatment of Epilepsy and Related Issues in the Mentally Retarded and Developmentally Disabled Patient: Role of Vagus Nerve Stimulator. Epilepsy and Behavior. 2002;3(6, suppl.):S41-4. Lotze TL and Wilfong AA. Zonisamide treatment for symptomatic infantile spasms. Neurology. 2004;62:296-8. Wilfong AA. Zonisamide Monotherapy for Epilepsy in Children and Young Adults. Pediatric Neurology. 2005;32(2):77-80. Wilfong AA and Schultz RJ. Zonisamide for Absence Seizures. Epilepsy Research. 2005;64(1-2):31-4. 11
  12. 12. Wilfong AA and Willmore JL. Zonisamide – A Review of Experience and Use in Partial Seizures (Invited Review). Neuropsychiatric Disease and Treatment. 2006;2(3):269-80. Wilfong AA and Schultz RJ. Vagus Nerve Stimulation for the Treatment of Epilepsy in Rett Syndrome. Developmental Medicine and Child Neurology. 2006;48(8):683-6. Brunetti-Pierri N, Wilfong AA, Hunter JV, and Craigen WJ. A Severe Case of Dentataorubro-Pallidoluysian Atrophy (DLPRA) with Microcephaly, Very Early Onset of Seizures, and Cerebral White Matter Involvement. Neuropediatrics. 2006;37:308-11. Takei, H, Wilfong AA, Yoshor D, Armstrong DL, Bhattacharjee MB. Evidence of Increased Cell Proliferation in the Hippocampus in Children with Ammon’s Horn Sclerosis. Pathology International. 2007;57:76-81. Malphrus AD, Wilfong AA. Use of the Newer AED’s in Pediatric Epilepsies. Current Treatment Options in Neurology. 2007;9(4):256-67. Wilfong AA. Complications and consequences of epilepsy surgery, ketogenic diet and vagus nerve stimulation. Seminars in Pediatric Neurology. 2007;14(4):201-3. Wilfong AA. Monotherapy in children and infants. Neurology. 2007;69:S17-S22. BOOK CHAPTERS: Wilfong AA and Fishman MA. Infectious and Parainfectious Causes of Static Encephalopathy. In: Miller G and Ramer JC, eds. Static Encephalopathies of Infancy and Childhood. New York: Raven Press, 1992:301-10. Wilfong AA. Pediatric Neurology Secrets. In: Rolak LA, ed. Neurology Secrets. Philadelphia: Hanley and Belfus, Inc., 1992:339-64. Wilfong AA. Pediatric Neurology Secrets. In: Rolak LA, ed. Neurology Secrets, 2nd ed. Philadelphia: Hanley and Belfus, Inc., 1998:329-352. Wilfong AA. Pediatric Neurology Secrets. In: Rolak LA, ed. Neurology Secrets, 3rd ed. Philadelphia: Hanley and Belfus, Inc., 2001:343-366. Wilfong AA. Pediatric Neurology Secrets. In: Rolak LA, ed. Neurology Secrets, 4th ed. Philadelphia: Hanley and Belfus, Inc., 2004:373-388. 12
  13. 13. Wilfong AA. Pediatric Epilepsy. In: Bromfield EB, Cavazos JE, Sirven JI, eds. An Introduction to Epilepsy. Bethesda, MD: Rogawski MA National Institute of Neurological Disorders and Stroke, 2006. Wilfong AA. Overview of the classification, etiology, and clinical features of pediatric seizures and epilepsy. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. Wilfong AA. Epilepsy syndromes in children. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. Wilfong AA. Treatment of seizures and epileptic syndromes in children. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. Wilfong AA. Clinical and laboratory diagnosis of seizures in infants and children. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. Wilfong AA. Clinical features and complications of status epilepticus in children. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. Wilfong AA. Management of status epilepticus in children. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. Nguyen T, Kaplan PW, and Wilfong AA. Nonepileptic paroxysmal disorders in children. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. Nguyen T, Kaplan PW, and Wilfong AA. Nonepileptic paroxysmal disorders in infancy. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007. ABSTRACTS: Wilfong AA, Romanchuk KG, and Lowry NJ. Autosomal Dominant Spinocerebellar Degeneration – A New Clinical Association. 22nd Canadian Congress of Neurological Sciences Meeting. Vancouver, British Columbia 1987. Wilfong AA, Killian JM, and Appel SH. A Single Neurophysiological Test Used to Quantitate ALS Progression. 26th Canadian Congress of Neurological Sciences Meeting. Halifax, Nova Scotia 1991. Wilfong AA. Clinical Evidence Supporting an Immunological Basis for the Opsoclonus-Myoclonus Syndrome. 26th Canadian Congress of Neurological Sciences Meeting. Halifax, Nova Scotia 1991. 13
  14. 14. Wilfong AA. Control of Intractable Photic Epilepsy with Eye Patching. 29th Canadian Congress of Neurological Sciences Meeting. St John’s, Newfoundland 1994. Wilfong AA. Postictal Enhancement on MRI. 29th Canadian Congress of Neurological Sciences Meeting. St John’s, Newfoundland 1994. Yager JY, Wilfong AA, and Lowry NJ. Iron Deficiency Anemia: A Frequent Cause of Transient Neurologic Deficit/Stroke in Children. 29th Canadian Congress of Neurological Sciences Meeting. St John’s, Newfoundland 1994. Lowry NJ, Wilfong AA, and Griebel RW. Gelastic Seizures After Hemispherectomy. 6th International Cleveland Clinic-Bethel Epilepsy Symposium. Bethel, Germany 1995. Membership of the CACN-L. CACN-L: A Discussion Group for Canadian Pediatric Neurologists on the Internet. 31st Canadian Congress of Neurological Sciences Meeting. London, Ontario 1996. Schwabe M and Wilfong AA. Good Surgical Outcome In Two Children With Rasmussen’s Encephalitis and Secondary Epileptogenesis. 52nd Annual Meeting American Epilepsy Society. Los Angeles, CA 1998. Schwabe M and Wilfong AA. Outcome of Intractable Epilepsy Patients Implanted with the Vagal Nerve Stimulator. 53rd Annual Meeting American Epilepsy Society. Orlando, FL 1999. Zupec-Kania BA, Werner RR, Wilfong AA, et al. Rapid Initiation of the Ketogenic Diet without the Traditional Fasting Period. 29th Annual Meeting of the Child Neurology Society. St Louis, MO 2000. Wilfong AA and Dickens DL. Efficacy and Tolerability Associated with the Use of Zonisamide for the Treatment of Generalized Seizures in Pediatric Patients. 53rd Annual Meeting of the American Academy of Neurology. Philadelphia, PA 2001. Wilfong AA. New Treatment Strategies for Epilepsy. 27th Annual Meeting of the Texas Association on Mental Retardation. Corpus Christi, TX 2002. Wilfong AA. Seizures and Seizure Management: Confirming Diagnosis and Assessing Treatment. 3rd Annual World Congress and Exposition on Disabilities. Orlando, FL 2002. 14
  15. 15. Lotze TE and Wilfong AA. Zonisamide as Potential Therapy for Symptomatic Infantile Spasms. 31st Annual Meeting of the Child Neurology Society. Washington, DC 2002. Arentz L, Owens J, Schultz R, and Wilfong A. Vagal Nerve Stimulation in Young Children: Predictors of a Rapid Response. 56th Annual Meeting of the American Epilepsy Society. Seattle, WA 2002. Owens J, Arentz L, Schultz R, and Wilfong A. Hemispherectomy in Two Cases of Medically Refractory Reflex Epilepsy. 56th Annual Meeting of the American Epilepsy Society. Seattle, WA 2002. Schultz RJ and Wilfong AA. Vagus Nerve Stimulation in Rett Syndrome. 56th Annual Meeting of the American Epilepsy Society. Seattle, WA 2002. Wilfong AA. Body MRI and Vagus Nerve Stimulation. 56th Annual Meeting of the American Epilepsy Society. Seattle, WA 2002. Conant LL and Wilfong AA. Cognitive and Behavioral Functioning in Childhood Absence Epilepsy. 31st Annual Meeting of the International Neuropsychological Society. Honolulu, HI 2003. Williams KL, Hosseini A, Wilfong AA. Oxcarbazepine Tolerability in Children Younger Than 12 Months. 57th Annual Meeting of the American Epilepsy Society. Boston, MA 2003. Wilfong AA. Zonisamide Monotherapy for Children and Young Adults. 57th Annual Meeting of the American Epilepsy Society. Boston, MA 2003. Schultz RJ and Wilfong AA. Use of Zonisamide in Patients with Absence Seizures: A Retrospective Chart Review. 57th Annual Meeting of the American Epilepsy Society. Boston, MA 2003. Bhattacharjee MB, Goodman JC, Wilfong AA, et al. Dual Pathology in Rasmussen’s Disease. Annual Meeting of the Society for Pediatric Pathology. Vancouver, British Columbia 2004. Feng C and Wilfong AA. Zonisamide Tolerability in Infants 12 Months of Age and Younger. 33rd Annual Meeting of the Child Neurology Society. Ottawa, Ontario 2004. Malphrus AD and Wilfong AA. Zonisamide: Safety in Pediatric and Young Adult Patients. 58th Annual Meeting of the American Epilepsy Society. New Orleans, LA 2004. 15
  16. 16. Wilfong AA, Constantine S, McCague K, D’Souza J. Oxcarbazepine Added to Other Sodium Channel Blockers or Antiepileptic Drugs Improves Seizure Control in Children with Refractory Seizures. 58th Annual Meeting of the American Epilepsy Society. New Orleans, LA 2004. Rodrigues RS, Schultz RJ, Wilfong AA. Effect of Diazepam Rectal Gel Use on Quality of Life in Pediatric Patients. 58th Annual Meeting of the American Epilepsy Society. New Orleans, LA 2004. Chapman KE, Edmonds JL, Wilfong AA. Changes in Laryngoscopic Evaluation Before and After Vagus Nerve Stimulator Implantation. 58th Annual Meeting of the American Epilepsy Society. New Orleans, LA 2004. Le Pichon JB, Baker MS, Abid F, Chapman KE, Wilfong AA. Outcome Following VNS Placement in Children in a Single Large Tertiary Care Institution. 26th International Epilepsy Congress. Paris, France 2005. Malphrus AD, Schultz RJ, McKee JA, Chapman KE, Wilfong AA. Racial and Ethnic Bias in the Selection of Therapy for Epilepsy. 26th International Epilepsy Congress. Paris, France 2005. Malphrus AD, Schultz RJ, McKee JA, Chapman KE, Wilfong AA. The Effects of the Ketogenic Diet Comparing Seizure Type with Seizure Control. 59th Annual Meeting of the American Epilepsy Society. Washington, DC 2005. Schexnayder LK, Yoshor D, Chapman KE, Schultz RJ, Wilfong AA. Reduction in Seizure Burden and Functional Outcome after Hemispherectomy in Pediatric Patients: A Retrospective Chart Review. 59th Annual Meeting of the American Epilepsy Society. Washington, DC 2005. Sheldon MH, Lu Y, Ljungberg C, Wieck GK, Mahmoud S, Bhattacharjee MB, Armstrong DL, Shaw CA, Verma A, Wilfong AA, Yoshor D, Mathern GW, Swann JW, D’Arcangelo G. Distinct Gene Transcription Signatures of Neuronal Populations in Epileptic Patients with Cortical Dysplasia. 59th Annual Meeting of the American Epilepsy Society. Washington, DC 2005. Malphrus AD, Schultz RJ, Wilfong AA. “Only the Spoon Knows What Is Stirring in the Pot”: Two Cases of Eating Epilepsy Induced by Spoons. 60th Annual Meeting of the American Epilepsy Society. San Diego, CA 2006. Wilfong AA, Duggan DT, Bradshaw TJ. Pregabalin Therapy in Pediatric Patients with Intractable Epilepsy. 60th Annual Meeting of the American Epilepsy Society. San Diego, CA 2006. 16
  17. 17. Goldman AM, Burgess DL, Gibbs RA, Chapman KE, Wilfong AA, Hrachovy RA, Foreman PJ, Goldsmith IL, Verma A, Hill MJ, Noebels JL. The Prevalence of Inter-Ictal Cardiac Arrhythmias and LQT Gene Variants in Patients with Idiopathic Epilepsy. 60th Annual Meeting of the American Epilepsy Society. San Diego, CA 2006. Wilfong AA, Malphrus AD, Yoshor D, Bhattacharjee MB. Pathological results in 46 consecutive pediatric temporal lobe epilepsy surgery cases. 27th International Epilepsy Congress. Singapore 2007. Malphrus AD, Schultz RJ, Wilfong AA. Rasmussen’s syndrome: Characterizing the course of nine pediatric patients. 27th International Epilepsy Congress. Singapore 2007. Bradshaw TJ, Evankovich KD, Chapieski ML, Wilfong AA. Intellectual and Academic Decline in Children with Intractable Seizures. 61st Annual Meeting of the American Epilepsy Society. Philadelphia, PA 2007. Schultz RJ and Wilfong AA. Vagus Nerve Stimulation in the Treatment of Myoclonic Astatic Epilepsy (Doose Syndrome). 61st Annual Meeting of the American Epilepsy Society. Philadelphia, PA 2007. Wilfong AA. Clinical Neurophysiology in Epilepsy. 5th Annual Latin- American Congress of Clinical Neurophysiology. Puebla, Mexico, 2008. Wilfong AA. Vagus Nerve Stimulation for Treatment in Children. 5th Annual Latin-American Congress of Clinical Neurophysiology. Puebla, Mexico, 2008. Wilfong AA, Buck C, Ball K. Sturge-Weber Syndrome: Trends in Epilepsy Therapy. 62nd Annual Meeting of the American Epilepsy Society. Seattle, WA 2008. Laxer KD, Wilfong AA, Morris III GL, Andermann F. Pilot Study of Rituximab to Treat Chronic Focal Encephalitis. 62nd Annual Meeting of the American Epilepsy Society. Seattle, WA 2008. 17

×